(Q53317233)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375436%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

editorial

0 references

title

Aligning the evidence with practice: NICE guidelines for drug treatment of Alzheimer's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375436%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375436%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Anne Corbett

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375436%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

author name string

Samantha Sharp

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375436%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

publication date

1 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375436%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

24 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375436%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375436%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375436%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

page(s)

327-329

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21375436%20AND%20SRC:MED&resulttype=core&format=json

Survival times in people with dementia: analysis from population based cohort study with 14 year follow-up

24 January 2020

cites work

1 reference

Attainment of treatment goals by people with Alzheimer's disease receiving galantamine: a randomized controlled trial

21 January 2018

1 reference

Patterns of decline and evidence of subgroups in patients with Alzheimer's disease taking galantamine for up to 48 months

21 January 2018

1 reference

The cognitive benefits of galantamine are sustained for at least 36 months: a long-term extension trial

21 January 2018

1 reference

Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial.

21 January 2018

1 reference

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease

21 January 2018

1 reference

IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease

21 January 2018

1 reference

Access to diagnostic evaluation and treatment for dementia in Europe.

21 January 2018

1 reference